Serum creatine phosphokinase levels and prednisone treated muscle weakness

Theodore L. Munsat, Walter G. Bradley

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

Evidence is cited from the literature and from personal experience with the 'inflammatory' form of facioscapulohumeral syndrome that the creatine phosphokinase reduction occurring during pharmacologic treatment of various neuromuscular diseases does not necessarily imply therapeutic benefit.

Original languageEnglish (US)
Pages (from-to)96-97
Number of pages2
JournalNeurology
Volume27
Issue number1
DOIs
StatePublished - Jan 1977
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Serum creatine phosphokinase levels and prednisone treated muscle weakness'. Together they form a unique fingerprint.

  • Cite this